# Prognostic Predictors of Response to Hypoglycemic Therapy

> **NCT03804411** · PHASE4 · UNKNOWN · sponsor: **Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health** · enrollment: 800 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Automatic system guided treatment
- **DRUG:** Standard treatment

## Key facts

- **NCT ID:** NCT03804411
- **Lead sponsor:** Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-08-01
- **Primary completion:** 2020-03
- **Final completion:** 2020-05
- **Target enrollment:** 800 (ESTIMATED)
- **Last updated:** 2020-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03804411

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03804411, "Prognostic Predictors of Response to Hypoglycemic Therapy". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03804411. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*